Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages

References

• Huston SM, Mody CH. Cryptococcosis: an emerging respiratory mycosis. Clin Chest Med. 2009;30:253–64, vi.
   PubMed Web of Science ®Google Scholar
• Smith RM, Mba-Jonas A, Tourdjman M, et al. Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest. PLoS One. 2014;9:e88875.
   PubMed Web of Science ®Google Scholar
• Ngamskulrungroj P, Chang Y, Sionov E, et al. The primary target organ of cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model. MBio. 2012;3.
   PubMed Web of Science ®Google Scholar
• Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995;21:28–34. discussion 5–6.
   PubMed Web of Science ®Google Scholar
• Buchanan KL, Doyle HA. Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice. Infect Immun. 2000;68:456–462.
   PubMed Web of Science ®Google Scholar
• Uicker WC, McCracken JP, Buchanan KL. Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system. Med Mycol. 2006;44:1–11.
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Yates JL, Lipscomb MF. Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J Exp Med. 1991;173:793–800.
   PubMed Web of Science ®Google Scholar
• Angkasekwinai P, Sringkarin N, Supasorn O, et al. Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts. Infect Immun. 2014;82:3880–3890.
   PubMed Web of Science ®Google Scholar
• Milam JE, Herring-Palmer AC, Pandrangi R, et al. Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector. Infect Immun. 2007;75:4951–4958.
   PubMed Web of Science ®Google Scholar
• Muller U, Piehler D, Stenzel W, et al. Lack of IL-4 receptor expression on T helper cells reduces T helper 2 cell polyfunctionality and confers resistance in allergic bronchopulmonary mycosis. Mucosal Immunol. 2012;5:299–310.
   PubMed Web of Science ®Google Scholar
• Kechichian TB, Shea J, Del Poeta M. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect Immun. 2007;75:4792–4798.
   PubMed Web of Science ®Google Scholar
• Leopold Wager CM, Hole CR, Wozniak KL, et al. Cryptococcus and phagocytes: complex interactions that influence disease outcome. Front Microbiol. 2016;7:105.
   PubMed Web of Science ®Google Scholar
• Charlier C, Nielsen K, Daou S, et al. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun. 2009;77:120–127.
   PubMed Web of Science ®Google Scholar
• Arora S, Olszewski MA, Tsang TM, et al. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans. Infect Immun. 2011;79:1915–1926.
   PubMed Web of Science ®Google Scholar
• Sabiiti W, Robertson E, Beale MA, et al. Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis. J Clin Invest. 2014;124:2000–2008.
   PubMed Web of Science ®Google Scholar
• Ma H, Hagen F, Stekel DJ, et al. The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation. Proc Natl Acad Sci U S A. 2009;106:12980–12985.
   PubMed Web of Science ®Google Scholar
• Hatthakaroon C, Pharkjaksu S, Chongtrakool P, et al. Molecular epidemiology of cryptococcal genotype VNIc/ST5 in Siriraj Hospital, Thailand. PLoS One. 2017;12:e0173744.
   PubMed Web of Science ®Google Scholar
• Supasorn O, Sringkarin N, Srimanote P, et al. Matrix metalloproteinases contribute to the regulation of chemokine expression and pulmonary inflammation in Cryptococcus infection. Clin Exp Immunol. 2016;183:431–440.
   PubMed Web of Science ®Google Scholar
• Cho JS, Oh YJ, Kim OS, et al. The effects of arginase inhibitor on lung oxidative stress and inflammation caused by pneumoperitoneum in rats. BMC Anesthesiol. 2015;15:129.
   PubMed Web of Science ®Google Scholar
• Voelz K, Lammas DA, May RC. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun. 2009;77:3450–3457.
   PubMed Web of Science ®Google Scholar
• Davis MJ, Tsang TM, Qiu Y, et al. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio. 2013;4:e00264–13.
   PubMed Web of Science ®Google Scholar
• Leopold Wager CM, Wormley FL Jr. Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections. Mucosal Immunol. 2014;7:1023–1035.
   PubMed Web of Science ®Google Scholar
• Price MS, Perfect JR. Host defenses against cryptococcosis. Immunol Invest. 2011;40:786–808.
   PubMed Web of Science ®Google Scholar
• Stenzel W, Muller U, Kohler G, et al. IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am J Pathol. 2009;174:486–496.
   PubMed Web of Science ®Google Scholar
• Thompson GR 3rd, Albert N, Hodge G, et al. Phenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection. Infect Immun. 2014;82:3058–3065.
   PubMed Web of Science ®Google Scholar
• Bojarczuk A, Miller KA, Hotham R, et al. Cryptococcus neoformans intracellular proliferation and capsule size determines early macrophage control of infection. Sci Rep. 2016;6:21489.
   PubMed Web of Science ®Google Scholar
• Freij JB, Fu MS, De Leon Rodriguez CM, et al. Conservation of intracellular pathogenic strategy among distantly related cryptococcal species. Infect Immun. 2018;86.
   PubMed Web of Science ®Google Scholar
• Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593–604.
   PubMed Web of Science ®Google Scholar
• Hancock A, Armstrong L, Gama R, et al. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol. 1998;18:60–65.
   PubMed Web of Science ®Google Scholar
• Kang CM, Jang AS, Ahn MH, et al. Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am J Respir Cell Mol Biol. 2005;33:290–296.
   PubMed Web of Science ®Google Scholar
• Blackstock R, Murphy JW. Role of interleukin-4 in resistance to Cryptococcus neoformans infection. Am J Respir Cell Mol Biol. 2004;30:109–117.
   PubMed Web of Science ®Google Scholar
• Muller U, Stenzel W, Kohler G, et al. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol. 2007;179:5367–5377.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang F, Tompkins KC, et al. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol. 2009;175:2489–2500.
   PubMed Web of Science ®Google Scholar
• Murdock BJ, Teitz-Tennenbaum S, Chen GH, et al. Early or late IL-10 blockade enhances Th1 and Th17 effector responses and promotes fungal clearance in mice with cryptococcal lung infection. J Immunol. 2014;193:4107–4116.
   PubMed Web of Science ®Google Scholar